Competitors of Hindustan Unilever Ltd in the Personal Care Sector
Stock Name | Market Cap | Current Price | High / Low | Stock P/E | Book Value | Dividend Yield | ROCE | ROE | Face Value |
---|---|---|---|---|---|---|---|---|---|
Honasa Consumer Ltd | 13,183 Cr. | 406 | 547/256 | 103 | 34.7 | 0.00 % | 17.1 % | % | 10.0 |
Ambica Agarbathies Aroma & Industries Ltd | 45.6 Cr. | 26.5 | 43.2/23.2 | 59.0 | 0.00 % | 5.07 % | 3.65 % | 10.0 | |
Ador Multi Products Ltd | 16.6 Cr. | 35.5 | 45.9/29.8 | 23.2 | 0.00 % | 33.6 % | 26.7 % | 10.0 | |
Kaya Ltd | 567 Cr. | 434 | 702/267 | 174 | 0.00 % | 80.4 % | % | 10.0 | |
Jyothy Labs Ltd | 18,583 Cr. | 504 | 596/333 | 49.6 | 49.2 | 0.69 % | 27.0 % | 21.2 % | 1.00 |
JHS Svendgaard Laboratories Ltd | 198 Cr. | 25.2 | 39.5/15.5 | 21.7 | 0.00 % | 1.69 % | 2.36 % | 10.0 | |
Godrej Industries Ltd | 34,059 Cr. | 1,012 | 1,314/602 | 69.4 | 238 | 0.00 % | 5.59 % | 0.65 % | 1.00 |
Godrej Consumer Products Ltd | 1,32,788 Cr. | 1,300 | 1,542/960 | 75.7 | 123 | 1.15 % | 19.0 % | 56.0 % | 1.00 |
Emami Ltd | 29,064 Cr. | 666 | 860/417 | 39.3 | 56.0 | 1.20 % | 31.7 % | 30.0 % | 1.00 |
Dabur India Ltd | 99,090 Cr. | 559 | 672/489 | 53.6 | 55.7 | 0.98 % | 22.3 % | 19.2 % | 1.00 |
Cupid Ltd | 1,984 Cr. | 73.9 | 142/25.3 | 43.2 | 7.65 | 0.00 % | 27.1 % | 20.8 % | 1.00 |
Bajaj Consumer Care Ltd | 3,121 Cr. | 219 | 289/200 | 21.3 | 58.2 | 1.37 % | 22.8 % | 18.8 % | 1.00 |
Colgate-Palmolive (India) Ltd | 90,846 Cr. | 3,340 | 3,893/2,004 | 64.2 | 68.9 | 1.44 % | 96.8 % | 74.5 % | 1.00 |
Procter & Gamble Hygiene and Health Care Ltd | 52,362 Cr. | 16,131 | 19,250/15,306 | 77.6 | 239 | 0.65 % | 112 % | 78.4 % | 10.0 |
Gillette India Ltd | 27,124 Cr. | 8,323 | 9,560/5,950 | 65.9 | 298 | 0.54 % | 58.2 % | 42.0 % | 10.0 |
Hindustan Unilever Ltd | 6,30,090 Cr. | 2,682 | 3,035/2,170 | 61.0 | 218 | 1.57 % | 27.2 % | 20.2 % | 1.00 |
Industry Average | 80,932.79 Cr | 2,233.57 | 60.32 | 107.77 | 0.60% | 36.72% | 29.60% | 4.94 |
About the Author
Getaka
Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.